Search for a doctor

Jolanta M. Durski, M.D.

  1. Nuclear Medicine Specialist
Request an Appointment

Publications

  1. Toro-Tobon D, Morris JC, Hilger C, Peskey C, Durski JM, Ryder M. Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers. Thyroid. 2024 Jan; 34 (1):70-81 Epub 2023 Dec 12
    View PubMed
  2. Bogsrud T, Jacobsen M, Durski J, Larsen E, Engelsen O, Haskjold OI, Castillejo M, Bach-Gansmo T, Nostrand DV. Letter to the Editor: Repeat Redifferentiation of Radioiodine Refractory BRAF(V600E) Mutated Thyroid Cancer with Dabrafenib. Thyroid 2023 Jun; 33 (6):771-773 Epub 2023 May 30
    View PubMed
  3. Durski JM, Hruska CB, Bogsrud TV, Ryder M, Johnson GB. 123I Scan With Whole-Body Retention Measurement at 48 Hours for Simplified Dosimetry Before 131I Treatment of Metastatic Thyroid Cancer. Clin Nucl Med. 2021 Mar 1; 46 (3):e151-e153
    View PubMed
  4. Parvinian A, Martin-Macintosh EL, Goenka AH, Durski JM, Mullan BP, Kemp BJ, Johnson GB. (11)C-Choline PET/CT for Detection and Localization of Parathyroid Adenomas. AJR Am J Roentgenol. 2018 Feb; 210 (2):418-422 Epub 2017 Nov 15
    View PubMed
  5. Merten MM, Castro MR, Zhang J, Durski J, Ryder M. Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules. Thyroid. 2017 Jan; 27 (1):95-102 Epub 2016 Dec 05
    View PubMed
  6. Stan MN, Durski JM, Brito JP, Bhagra S, Thapa P, Bahn RS. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment. Thyroid. 2013 May; 23 (5):620-5
    View PubMed
  7. Cheville AL, Brinkmann DH, Ward SB, Durski J, Laack NN, Yan E, Schomberg PJ, Garces YI, Suman VJ, Petersen IA. The addition of SPECT/CT lymphoscintigraphy to breast cancer radiation planning spares lymph nodes critical for arm drainage. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85: (4)971-7.
    View PubMed
  8. Karantanis D, Durski JM, Lowe VJ, Nathan MA, Mullan BP, Georgiou E, Johnston PB, Wiseman GA. 18F-FDG PET and PET/CT in Burkitt's lymphoma. Eur J Radiol. 2010 Jul; 75(1):e68-73. Epub 2009 Aug 27.
    View PubMed
  9. Summers HG, Loftus EV Jr, Sebo TJ, Durski JM. Appendiceal carcinoid mimicking a Meckel's diverticulum on Tc-99m pertechnetate imaging. Clin Nucl Med. 2010 Apr; 35: (4)277-9.
    View PubMed
  10. Karantanis D, Durski JM, Lowe VJ, Nathan MA, Mullan BP, Georgiou E, Johnston PB, Wiseman GA. 18 F-FDG PET and PET/CT in Burkitt's lymphoma. Eur J Radiol. 2010; 75(1):e68-e73.
  11. Karantanis D, Subramaniam RM, Peller PJ, Lowe VJ, Durski JM, Collins DA, Georgiou E, Ansell SM, Wiseman GA. The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma. Clin Lymphoma Myeloma. 2008 Apr; 8: (2)94-9.
    View PubMed
  12. Meyers A, Durski JM, Snow AA. Nuclear medicine gastrointestinal bleeding examination utilizing an UltraTag kit reveals unusual bone marrow and hepatic uptake: a case study report. JNMT. 2004; 32(1):16-8.
  13. Durski JM. Young patient with wrist pain - Continuing Medical Education. Nuclear Medicine Review - Central and Eastern Europe. 2002; 5(1):67-8.
    View PubMed
  14. Durski JM, Twist CJ, Goris M. A case from Stanford University. Neuroblastoma with diffuse bone marrow involvement. Nucl Med Rev Cent East Eur. 2001; 4(1):61-2.
    View PubMed
  15. Durski JM, Srinivas S, Segall G. Comparison of FDG-PET and bone scans for detecting skeletal metastases in patients with non-small cell lung cancer. Clinical Positron Imaging. 2000; 3(3):97-105.
    View PubMed
  16. Durski JM, Weigel RJ, McDougall IR. Recombinant human thyrotropin (rh TSH) in the management of differentiated thyroid cancer. Nuclear Medicine Communications. 2000; 21(6):521-8.
    View PubMed
  17. Conti PS, Durski JM, Bacquai F, Grafton ST, Singer PA. Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid. 1999; 9(8):797-804.
    View PubMed
  18. Bialobrzeska B, Bialobrzeski J, Liniecki J, Wdowczyk J. Stability of 99mTc-Mebrofenin and 99mTc-HEPIDA in human blood. Probl Med Nukl. 1993; 7(14):141-147.
PST-20223380